Candidates for 2023 Board of Directors

November 01, 2022

The Endocrine Society Nominating Committee met in late October 2022 to discuss candidates for the 2023 Board of Directors. Nominees were identified from candidates who submitted completed packages as part of the Call for Nominations distributed to all members earlier this year.

The members identified below have a wide range of backgrounds and experiences to complement the current Board of Directors and reflect the Society membership.  Specifically, we looked at how each epitomizes the Society core competencies:

  • Organizational Knowledge and Stewardship—Understands and embodies the association’s core values, mission and strategic priorities.
  • Strategic Thinking and Leadership—Demonstrates leadership attributes that allow them to positively influence the decision-making process by effectively aligning tasks, priorities, and resources in a thoughtful and strategic way.
  • Communication—Demonstrates skills and leadership in communicating efficiently, respectfully, and transparently.
  • Collaboration—Appreciates the unique views and opinions of others when building consensus.

The Committee also wanted to ensure the Board as a whole reflected diversity in professional roles, geographic and ethnic diversity, and demonstrated experience in strategic leadership and innovation.

Nominees for 2032 Board Positions

President-Elect (one-year term)

To be elected by membership; election ballot to launch in early January, 2023.


John Newell-Price, MD, PhD FRCP
University of Sheffield
Sheffield, United Kingdom

Paul Stewart, MD, FRCP
University of Leeds
Leeds, United Kingdom

Directors (three-year term)


Ricardo Azziz, MD, MBA, MPH
University of Alabama
Birmigham, AL


Maria Fleseriu, MD
Oregon Health & Science University
Portland, OR


W. Lee Kraus, PhD
University of Texas Southwestern Medical Center
Dallas, TX



University of Western Australia
Crawley, Australia


Early Career Director (three-year term, non-voting)


Stanley Andrisse, MBA, PhD
Howard University
Washington, DC

The Nominating Committee believes the future Board of Directors is well-positioned to implement our mission and vision to support our members.

As part of the new governance changes approved in 2019, there is a new approach for elections. Voting members will receive a ballot in early January, 2023 to vote on the candidates for the President-Elect position. The Directors are presented as a slate of candidates and will stand as presented, pending a 30-day petition process.


The slate presented is the recommendation from the Nominating Committee. If a member does not think the slate of candidates is reflective of the membership, he/she may choose to submit a petition candidate. The petition process does not apply to the candidates for election to the President-elect position.

Petition candidates must email [email protected] with an intent to submit a petition, and will be sent instructions for gathering member signatures. Petitions with three percent of voting members as of December 31st of the previous year, not more than ten percent (10%) from one institution/organization, will result in a runoff election. The run-off slate will include the petitioner(s) and individuals proposed by the Nominating Committee. Any candidate brought forth by petition must submit the requisite candidate information form(s). The new Board members will be determined by the highest votes in the election.

Completed petitions must be submitted by December 15, 2022. If none are submitted, the slate will stand as presented.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.